Patents by Inventor Pedro José ALCOLEA ALCOLEA

Pedro José ALCOLEA ALCOLEA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular adjuvant and vaccine
    Patent number: 11179462
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: November 23, 2021
    Assignees: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS, CZ VETERINARIA S.A.
    Inventors: Pedro José Alcolea Alcolea, Ana María Alonso Ayala, Vicente Emilio Larraga Rodríguez De Vera
  • MOLECULAR ADJUVANT AND VACCINE
    Publication number: 20200360512
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Application
    Filed: January 16, 2020
    Publication date: November 19, 2020
    Inventors: Pedro José ALCOLEA ALCOLEA, Ana María ALONSO AYALA, Vicente Emilio LARRAGA RODRÍGUEZ DE VERA
  • Molecular adjuvant and vaccine
    Patent number: 10568960
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: February 25, 2020
    Assignee: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS
    Inventors: Pedro José Alcolea Alcolea, Ana María Alonso Ayala, Vincente Emilio Larraga Rodríguez De Vera
  • MOLECULAR ADJUVANT AND VACCINE
    Publication number: 20180289796
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Application
    Filed: May 23, 2016
    Publication date: October 11, 2018
    Inventors: Pedro José ALCOLEA ALCOLEA, Ana María ALONSO AYALA, Vicente Emilio LARRAGA RODRÍGUEZ DE VERA